Get inside Wall Road with StreetInsider Premium. Declare your 1-week free trial here.
Strategic funding and advisory settlement permits the worldwide growth of Novamind’s psychedelic clinic mannequin
TORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc. (CSE:NM)(OTCQB: NVMDF)(FSE:HN2) (“Novamind” or the “Firm”), a number one psychological well being firm specialised in psychedelic medication, at present introduced a strategic funding and advisory settlement (“Strategic Funding Settlement”) with Bienstar Wellness Corp. (“Bienstar”)-an early-stage Latin American psychological well being company-to help within the improvement of Latin America’s first community of integrative psychological well being clinics treating sufferers with psychedelic medication and different revolutionary remedies.
The Strategic Funding Settlement features a US$500,000 funding by Novamind into Bienstar’s US$1,250,000 seed spherical, and a strategic advisory settlement offering Bienstar with entry to Novamind’s famend medical commonplace working procedures (SOPs). Following closing of the Strategic Funding Settlement, Novamind will personal 8.33% of Bienstar on a completely diluted foundation. Bienstar is headquartered in Uruguay and has an preliminary give attention to coming into Latin American markets together with Brazil, Mexico, Uruguay, Peru and Panama.
“Novamind operates best-in-class psychiatry clinics and medical analysis websites, with a confirmed skill to duplicate our clinic mannequin within the U.S. Our settlement with Bienstar is an thrilling alternative to export our medical experience and capabilities into worldwide markets,” mentioned Yaron Conforti, Novamind CEO and Director. “Partnering with native operators permits us to disseminate Novamind’s finest practices and SOPs globally, with minimal funding and managed danger, in the end increasing entry to psychedelic medication and revolutionary psychological healthcare on a worldwide scale.”
Bienstar’s management workforce of achieved healthcare entrepreneurs contains Chief Medical Officer, Dr. Bruno Rasmussen, a pioneer and one of many main names in psychedelic medication in Brazil. Since 1994, Dr. Rasmussen has handled greater than 2,000 sufferers with ibogaine for substance use problems and different psychiatric circumstances on the Hospital da Santa Casa de Ourinhos. He’s co-founder and former director of the International Ibogaine Therapists Alliance (GITA) and one of many authors of the 2014 article, “Treating drug dependence with assistance from ibogaine: a retrospective examine.” His work influenced the regulation of hospital use of ibogaine by the Drug Coverage Council of the State of So Paulo. He was additionally the first doctor and co-author of the one part III examine in Brazil with MDMA and is MAPS-trained in psychedelic-assisted psychotherapy.
Marco Algorta, CEO of Bienstar, acknowledged: “We’re proud to carry Novamind’s revolutionary remedies to Latin America, a area that might significantly profit from these strategies to enhance psychological well being and improve the lives of sufferers.”
About Novamind
Novamind is a number one psychological well being firm enabling protected entry to psychedelic medication by way of a community of clinics and medical analysis websites. Novamind offers ketamine-assisted psychotherapy and different novel remedies by way of its community of integrative psychological well being clinics and operates a full-service contract analysis group specialised in medical trials and evidence-based analysis for psychedelic medication. For extra data on how Novamind is enhancing psychological wellness and guiding individuals by way of their total therapeutic journey, go to novamind.ca.
About Bienstar
Bienstar Wellness is an organization centered on bringing different psychological well being remedies to Latin America. Bienstar will present psychedelic assisted psychotherapy with permitted substances, by way of a community of clinics throughout the area, together with Brazil, Mexico, Perú, Uruguay and Panama. Compliance is on the core of Bienstar’s values, and its operations are absolutely compliant with all native rules. Bienstar’s dedication is to assist sufferers with melancholy and temper problems, affecting over 16.3 million individuals in Brazil. For extra data, go to www.bienstar.life.
Contact Info
Novamind
Yaron Conforti, CEO and Director
Phone: +1 (647) 953 9512
Samantha DeLenardo, VP, Communications
E-mail: media@novamind.ca
Invoice Mitoulas, Investor Relations
E-mail: bill@novamind.ca
Ahead-Trying Statements
This information launch accommodates forward-looking statements. All statements aside from statements of historic truth included on this launch are forward-looking statements that contain dangers and uncertainties. There could be no assurance that such statements will show to be correct and precise outcomes and future occasions may differ materially from these anticipated in such statements. Vital elements that might trigger precise outcomes to vary materially from the Firm’s expectations together with the dangers detailed infrequently within the Firm’s public disclosure. The reader is cautioned to not place undue reliance on any forward-looking data. Ahead-looking statements contained on this information launch are expressly certified by this cautionary assertion. The forward-looking statements contained on this information launch are made as of the date of this information launch and the Firm will replace or revise publicly any of the included forward-looking statements as expressly required by relevant legal guidelines.
SOURCE: Novamind Inc.
View supply model on accesswire.com:
https://www.accesswire.com/674167/Novamind-Partners-with-Uruguay-Based-Bienstar-Wellness-to-Develop-Latin-Americas-First-Integrative-Mental-Health-Clinic-Network